Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
05/2003
05/15/2003CA2464615A1 Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides
05/15/2003CA2464614A1 Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides
05/15/2003CA2464531A1 Soluble cd40l(cd154) as a prognostic marker of atherosclerotic diseases
05/15/2003CA2462158A1 Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
05/15/2003CA2459745A1 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
05/14/2003EP1310797A2 Method of monitoring neuroprotective treatment
05/14/2003EP1310571A2 A Method of detecting and/or identifying adeno-associated virus (AVV) sequences and isolating novel sequences identified thereby
05/14/2003EP1310558A2 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
05/14/2003EP1310498A2 Pyrazoloquinolinone derivatives as protein kinase C inhibitors
05/14/2003EP1310494A1 PPAR (delta) ACTIVATORS
05/14/2003EP1310493A1 N-adamantylalkyl benzamide derivates as p2x7-receptor antagonists
05/14/2003EP1310491A1 Method for producing 1-substituted-1,2,3-triazole derivative
05/14/2003EP1310490A1 Gpr14 antagonist
05/14/2003EP1310249A1 Use of polyunsatured fatty acids for the primary prevention of major cardiovascular events
05/14/2003EP1310248A1 Pharmaceutical composition
05/14/2003EP1309721A2 Modulating multiple lineage kinase proteins
05/14/2003EP1309716A2 A method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis
05/14/2003EP1309706A2 Modulation of stem cell differentiation
05/14/2003EP1309704A2 Regulation of human membrane-type serine protease
05/14/2003EP1309700A2 Human phosphodiesterases
05/14/2003EP1309699A2 Elongase genes and uses thereof
05/14/2003EP1309697A2 Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme
05/14/2003EP1309693A2 Anti-dual integrin antibodies, compositions, methods and uses
05/14/2003EP1309685A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
05/14/2003EP1309684A2 Polynucleotides and polypeptides encoded thereby
05/14/2003EP1309620A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
05/14/2003EP1309609A2 Lactam compounds and their use as inhibitors of serine proteases and method
05/14/2003EP1309596A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases
05/14/2003EP1309594A1 Benzimidazole derivatives, preparation and therapeutic use thereof
05/14/2003EP1309590A1 Azaindole derivatives, process for their preparation, and their use as antitumor agents
05/14/2003EP1309589A2 Urea compounds and methods of uses
05/14/2003EP1309587A1 Cinnoline compounds
05/14/2003EP1309575A1 Biphenyl derivatives and their use as ppar-gamma receptor activators
05/14/2003EP1309573A1 Urethane derivatives
05/14/2003EP1309571A1 Non-steroidal inflammation inhibitors
05/14/2003EP1309564A2 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists
05/14/2003EP1309563A1 Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting protein kinases
05/14/2003EP1309560A1 Pyridine derivatives as inhibitors of p38
05/14/2003EP1309558A1 Aspartate derivative of amlodipine as calcium channel antagonist
05/14/2003EP1309557A1 Amlodipine hemimaleate
05/14/2003EP1309556A1 Amlodipine fumarate
05/14/2003EP1309555A1 Process for making amlodipine maleate
05/14/2003EP1309554A1 Amide derivative of amlodipine
05/14/2003EP1309552A1 Compounds and inhibitors of phospholipases
05/14/2003EP1309551A1 Indoline derivatives as 5ht2c antagonists
05/14/2003EP1309549A1 Acetamide derivatives and the use thereof as inhibitors of coagulation factors xa and viia
05/14/2003EP1309532A1 Method for obtaining cocoa bean polyphenol extracts, resulting extracts and uses thereof
05/14/2003EP1309355A1 Peptide and peptide mimetic conjugates with integrin-inhibitor properties
05/14/2003EP1309351A1 Dermatological formulation
05/14/2003EP1309337A2 Use of gadd34 or pcna polypeptides in the treatment of cerebral ischaemic damage
05/14/2003EP1309331A2 Medicine for fighting against sexual dysfunction
05/14/2003EP1309329A2 Therapeutic combination of a cetp inhibitor and atorvastatin
05/14/2003EP1309323A2 Method of treating angiogenesis-related disorders using benzoyl phenylacetic acid
05/14/2003EP1309322A2 Method of treating neurodegenerative disorders of the retina and optic nerve head
05/14/2003EP1309317A1 Pharmaceutical compositions comprising amlodipine maleate
05/14/2003EP1309316A2 Oral fast-melt dosage form of a cyclooxygenase-2 inhibitor
05/14/2003EP1192170B1 Propargyl phenyl ether a2a receptor agonists
05/14/2003EP1192169B1 C-pyrazole a2a receptor agonists
05/14/2003EP1189595B1 Ophthalmic compositions in form of aqueous gels
05/14/2003EP1180105B1 Substituted aza-oxindole derivatives
05/14/2003EP1175157A4 Low molecular weight polymannuronate
05/14/2003EP1140189B1 Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
05/14/2003EP1112266B1 Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same
05/14/2003EP1102746B1 Substituted phenylamidines with antithrombotic action
05/14/2003EP1045842B1 Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines
05/14/2003EP0979096B1 Treatment of infarcts through inhibition of nf-kappab
05/14/2003EP0954521B1 4- (thien-3-yl)methyl] imidazole derivatives having alpha2-adrenoceptor agonistic activity
05/14/2003EP0946550A4 PREPARATION OF 1S- 1a,2b,3b,4a(S*)]]-4- 7- 1-(3-CHLORO-2-THIENYL) METHYL]PROPYL]AMINO]-3H-IMIDAZO 4,5-b]PYRIDIN-3-yl]-N-ETHYL-2,3-DIHYDROXYCYCLOPENTANECARBOXAMIDE
05/14/2003EP0815255B1 Hormone and growth factor phosphoglycan mimetics from mycobacterium vaccae
05/14/2003EP0813541B1 Process for producing a protein
05/14/2003CN1418217A Fused pyrrole compounds, pharmaceutical composition containing the same, and the use thereof
05/14/2003CN1418216A Novel 2,3,4,5-tetrahydro-1H-[1,4] diazepino [1,7a]indole compound
05/14/2003CN1418215A Substituted beta-carbolines with IKB-kinase inhibiting activity
05/14/2003CN1418211A 苯并咪唑衍生物 Benzimidazole derivatives
05/14/2003CN1418199A Pyrimidine-4-one derivatives as LDL-PLA2 inhibitors
05/14/2003CN1418198A Crystalline salts of 7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl (methylsulfonyl)amino] pyrimidin-5-yl]-(3R5S)-3,5-dihydroxyhept-6-enojc acid
05/14/2003CN1418197A Piperidine and piperazine substituted N-hydroxyformamides as inhibitors of metalloproteinases
05/14/2003CN1418196A Pyridazinyl phenyl hydrazones useful against congestive heart failure
05/14/2003CN1418195A Therapeutic morpholino-substituted compounds
05/14/2003CN1418194A Amide compounds and use thereof
05/14/2003CN1418193A heterocyclic side chain containing metalloprotease inbibitors
05/14/2003CN1418192A Pharmaceutical compositions containing azetidine derivatives novel azetidine derivatives and preparation thereof
05/14/2003CN1418187A Carboxylic acid derivatives as IP antagonists
05/14/2003CN1418185A Aniline-derived ligands for thyroid receptor
05/14/2003CN1418121A Compound with 5-HT1A activity useful for treating disorders of outer retina
05/14/2003CN1418115A Coating that promotes endothelial Cell adherence
05/14/2003CN1418111A Novel Ligands and method for preparing same
05/14/2003CN1418109A Drugs for complications of diabetes and neuropathy and utilization thereof
05/14/2003CN1418106A 疫苗 Vaccine
05/14/2003CN1418102A 激素替代疗法 Hormone replacement therapy
05/14/2003CN1418100A Compounds with 5-HT activity useful for controlling visual field loss
05/14/2003CN1418096A IL-8 receptor antagonists
05/14/2003CN1418091A Pharmaceutical preparations
05/14/2003CN1418089A Pharmaceutical composition of glycogen phosphorylase inhibitors
05/14/2003CN1417333A Cloning, Expression and bioactivity of new actinion toxin
05/14/2003CN1417223A CR1 gene related to cell reconstitution, conduction and death
05/14/2003CN1417220A Prepn process, medicine prepn and new medicinal use of sophoricosids
05/14/2003CN1417206A Alkyl sulfonamide phenyl alkylamide compound and its prepn and medicinal use
05/14/2003CN1416891A Pile-treating Chinese medicine
05/14/2003CN1416875A 17-hydroxy C27 steroid compound and its synthesis and use
1 ... 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 ... 1595